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ABSTRACT
Role of the CD40-CD40 ligand in CD4+ T cell activation of monocyte
Interleukin-1 synthesis
by
David H. Wagner, Jr.
Most studies o f the induction of cytokine synthesis in monocytes have used an
exogenous triggering agent such as Lipolpoysaccharide (LPS). However, during
nonseptic chronic inflammatory responses (e.g., rheumatoid arthritis) monocyte
activation occurs as a result of T cell generated signals. This report demonstrated that
plasma membranes from anti-CD3 activated peripheral CD4+ T cells (TmA) but not
from resting CD4+ cells (TmR) induced monocytes to synthesize IL-1 in the absence of
costimulatory cytokines. The expression kinetics of the molecule(s) unique to activated
T cells which interact with monocyte receptors to induce IL-1 demonstrated that
optimal expression occurred at 6h post activation. This matched Lederman's, et al.,
(1992) previously reported kinetics of expression of CD40 ligand (CD40L) on activated
peripheral T cells, implicating the CD40-CD40L interaction as a candidate for the
initiator of IL-1 induction in monocytes. In this work, it was demonstrated that the
signal could be reduced up to 85% by addition of 5c8, a monoclonal anti-CD40L
antibody. In addition, a monoclonal anti-CD40 IgM (BL-C4) induced resting
monocytes to synthesize IL-1. Experiments demonstrated that crosslinking the CD40
molecules on monocytes was critical for IL-1 induction. TmAbut not TmR also upregulated cell surface expression of adhesion/costimulatory molecules on monocytes
including CD40, ICAM-1, and LFA-3. Anti-CD40 signating up-regulated expression
o f ICAM-1 and LFA-3. Experiments suggested that signaling through CD40 may
utilize a protein tyrosine kinase (PTK) mediated pathway but not a protein kinase C
mediated pathway and studies using THP-1, a premonocytic cell line, indicated that the
transcription factor, NF-kB, was activated through anti-CD40 signaling. Since CD40
ligand-transfected cells alone did not induce IL-1 but TmAdid, it was considered that
an additional costimulatory cell surface motecute was required. Preliminary
experiments suggested that CD69 may be required. In summary, these results indicate
that contact-dependent T cell-monocyte interactions, alone, can activate inflammatory
cytokine production by resting monocytes and that a critical component of this
interaction is the CD40-CD40L signaling event.
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Chapter 1

'

INTRODUCTION

Biology and Biochemistry of IL-1
Interleukin (IL.)-1 is a cytokine with numerous biological effects. When
produced in limited concentrations during a normal immune response, IL-1 helps
sustain the immune response by acting as a costimulus for T cell activation (Farrar et
al., 1980). For instance, IL-1 induces the expression of IL-2, a T cell growth factor,
in CD4+ T helper type 1 (Thl) cells. Each T cell subtype is designated by its ability to
produce specific cytokines. Furthermore, IL-1 induces expression of the IL-2 receptor
in all T cell subtypes, thus promoting T cell expansion. IL-1 also augments the ability
o f antigen presenting cells (APC) such as monocytes/macrophages, B cells, and
dendritic cells, to activate T cell-dependent immune responses by up-regulating the
expression of adhesion and costimulatory molecules on the APC cell surface (Dinarello,
1991). IL-1 is produced primarily by activated macrophages, however it has been
shown to be synthesized by a variety of cell types including fibroblasts, keratinocytes,
endothelial cells, smooth muscle cells, and synovial cells (Matsushima et al., 1985; and
Dinarello, 1984).
Overproduction of IL-1, as seen during chronic inflammatory diseases as well as
bacterial infection and septic shock, results in injurious effects such as tissue
destruction and exacerbation of host inflammatory responses. Tissue destruction results
from the induction type IV collagenase and elastase gene expression (Lomedico et al.,
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198S; and Dinarello, 1991). IL-1 amplifies inflammatory responses through the
induction o f phospholipase A2 synthesis which leads to the production of lipid
mediators of inflammation, leukotrienes, (Dinarello, 1991) and through induction of
etcosanoid synthesis, prostaglandin Ej, in synovial cells (Dayer et al., 1986). IL-1
increases the expression o f adhesion molecules including intracellular adhesion
molecule 1 (ICAM 1), vascular cell adhesion molecule (VCAM) and endothelialleukocyte adhesion molecule (ELAM) on the surface of surrounding tissues including
endothelial and vascular smooth muscle cells (Dinarello, 1991). These adhesion
molecules bind circulating neutrophils, lymphocytes and monocytes resulting in
expansion o f the inflammatory response.
Other biological effects of IL-1 as reviewed by Dinarello (1991) include the
induction o f inflammatory cytokine genes such as Tumor necrosis factor-a (TNFo), IL6 and IL-1 itself. IL-1 exhibits endocrine consequences including the induction of
Hpolysis in adipocytes, and glucocorticoids in adrenal glands, as well as increasing
production of prostaglandins, and promoting effects such as somnolence, anorexia,
hypoalgesia and fever in brain tissue. IL-1 also has been shown to induce kappa
immunoglobulin light chain synthesis, up-regulation of the T cell growth factor (TGF)p receptor and down-regulation of IL-1 receptor, tumor necrosis factor (TNF) receptor
and epidermal growth factor receptor.
The IL-1 designation refers to two separate proteins, IL-1 a and IL-lfl, which
are products of different genes but perform essentially the same biological functions
(Lomedico et al., 1985; and Auron et al., 1984). Although IL-1 a and IL -lp share
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only 26% amino acid identity each binds to the same receptors (type I and type II) and
with equal affinity (Dinarello, 1991). IL-1 a and IL-lp are synthesized as 33kD
precursors both of which are proteolytically processed to a 17kD mature form (Giri et
al., 1985). Precursor IL-1 a has biological activity but IL-1fl requires processing to the
mature form in order to bind to the IL-1 receptors (Black et al., 1988). Precursor ILl a reportedly is processed by calcium dependent proteases such as calpain (Kobayashi
et al., 1990), A specific enzyme for processing precursor IL-lfl, IL-lfl-converting
enzyme (ICE) that's localization apparently is restricted to monocytes/macrophages,
has been identified (Thomberry et al., 1992; and Kostura et al., 1989). Intracellular
IL-1 is found exclusively as the precursor form (Giri et al., 1985; Suttles et al., 1990)
white both forms have been detected extracellularly (Suttles et at., 1990; and personal
observations). Processing therefore must occur extracellularly or at the plasma
membrane. Other enzymes, though not accepted as the primary processing enzymes,
also cleave both IL-1 a and IL-lp to various biologically active sizes. It has been
demonstrated that cathepsin-G, collagenase, and etastase are capable of processing ILloc and IL -lp precursors (Hazuda et al., 1990), although these enzymes only may
process IL-1 precursors after tissue damage.
Neither IL-1« nor IL-lfl have an N-terminal or internal signal peptide sequence
(Hazuda et al., 1990) which is considered necessary for secreted proteins.
Furthermore, it has been reported that IL-1 is not associated with secretory vesicles or
transported across the endoplasmic reticulum (Singer et al., 1988; and Suttles et al.,
1990). Therefore, IL-1 a and IL-1 it must utilize some novel secretory mechanism. It

has been proposed (hat the principal mechanism of secretion is cell injury (Hogquist et
al., 1991). While this is an accepted mechanism ofIL-1 release, there is evidence that
some type of secretory mechanism distinct from the typical signal-peptide mechanism
of secretion does exist (Hazuda et al., 1988; Hazuda et al., 1990; Singer et al., 1988;
Hogquist et al., 1991; and Koch et al., 1990), We have seen that
ethylenediaminetetraacetic acid (EDTA) diminishes the ability of activated macrophages
to secrete IL -lp , suggesting that extracellular divalent cations such as calcium and
magnesium may play a role in the secretory mechanism of IL-1 (unpublished
observations).

Monocyte/Macrophage Activation Leading to Induction of IL-1
Most studies o f induction of IL-1 synthesis and secretion in
monocytes/macrophages have used the bacterial endotoxin, lipopolysaccharide ( LP5) a
potent stimulator of cytokine synthesis in monocytes/macrophages. While such studies
are certainly relevant to the induction of cytokines during septic conditions such as
bacterial infection and septic shock, IL-1 production in rheumatoid arthritis and other
chronic inflammatory autoimmune diseases is not mediated by LPS. It has been
reported that there are activated CD4+ T cells in the synovial tissues of patients with
rheumatoid arthritis (Jahn et al., 1987; Koch et al., 1990). T cells and
monocytes/macrophages form conjugates during a normal immune response and this
conjugate formation during abnormal chronic inflammatory responses may also result
in the overproduction of IL-1.

During antigen presentation events, T cells interact with macrophages in an
antigen dependent, major histocompatibility complex type II (MHC-II) restricted
fashion with cell-contact mediated and cytokine mediated signals resulting in mutual
activation of both T cells and macrophages. Studies of the interactions between T cells
and macrophages have demonstrated that the cell contact-mediated contribution is
critical for monocyte/macrophage activation (Stout, 1993; Stout and Suttles, 1992; and
Suttles et al., 1994). It was demonstrated that the activation of macrophages to
produce reactive nitrogen intermediates, nitric oxide, requires a combination of signals
(Tao and Stout, 1993). These signals provided by LPS and interferon-y (IFNy), a
cytokine produced by activated T helper type 1 (Thl) cells, lead to establishment of a
TN Fa autocrine loop (Stout, 1993; Stout and Suttles, 1992). It is welt established that
LPS induces the synthesis and secretion of TN Fa, as well as other inflammatory
cytokines (Sherry and Cerami, 1988). IFNy induces upregulation of cell surface
proteins including the TNFa receptor (Tsujimoto et al., 1986). Therefore, newly
synthesized and secreted TN Fa binds to its cell surface receptor and results in a
signaling cascade that induces effector functions such as production of nitric oxide and
interferon-p (IFNp) in the macrophage (Stout and Suttles, 1992). The necessity of the
TN Fa autocrine loop was confirmed since macrophages activated by LPS and IFNy in
the presence of anti-TNFa antibodies did not produce nitric oxide [effector function]
(Stout and Suttles, 1992; Oswald et al., 1992).
Later studies have demonstrated that activated T cells could replace the LPS
signal resulting in macrophage effector function. Stout and Bottomly (1989) have

6

shown that macrophages are activated to cytostatic activity by cell-contact mediated
interactions with T hl cells alone and by Th2 coupled with recombinant interferongamma (IFNy). Activated T hl cells produce IFNy whereas activated Th2 cells do not.
Stout and Suttles (1993) later showed that the signals necessary to induce cytostatic
activity in IFNy primed macrophage could be delivered by cell-contact mediated
interactions with murine Th2 cells. The activation signal could not be delivered by
supernatants of activated T cells (cytokines) or if cell contact was prevented. However,
paraformaldehyde fixed, activated T cells, either Thl or Th2, were able to deliver the
signal (Stout and Suttles, 1993). These reports indicate that a critical part of the signal
for macrophage activation is transduced through cell-contact mediated events.
These studies in murine systems have established that activated T cells through
cell-contact mediated events, induce early gene activation events in macrophages
(TNFa production) and in the presence of recombinant cytokines such as IFNy late
gene events are induced (cytostatic activity). Several molecules have been identified on
monocyte/macrophage cell surfaces which form receptor-ligand pairs with molecules on
activated T cells during conjugate formation (Figure 1). These molecules include:
Intracellular adhesion molecule [ICAM-1 also known as CDS4] (Springer, 1990),
Lymphocyte function-associated antigen [LFA-3 or CD58] (Webb et al., 1990), and
Very late activation antigen [VLA-4 or CDw49d] (Springer, 1990). B7.1, B7.2/CD80
[BB1] has been detected in very low concentrations on monocytes/macrophages, but
reportedly it can be up-regulated by IFNy (Freedman et al,, 1991). It has also been
demonstrated that CD40 is expressed on peripheral monocytes in extremely low
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Figure 1. Cell surface molecules on antigen presenting cells [APC] such as
monocytes/macrophages and the ligand counterparts on T cells.
Several cell surface receptor - ligand molecules have been identified during T
cclhmonocyte/macrophage conjugate formation. Molecules on monocyte/macrophage
cell surfaces include LFA-3, ICAM-1/ICAM-2, B7.0, B7.1, and B7.2 (though B7 is
expressed in low concentrations on monocytes (APC) but upregulatcd by cytokines such
as IFNy), and recently CD40. The corresponding ligands on T cells include CD2,
LFA-1, CD28/CTLA-4, and CD40 ligand. Potentially, any of these rcccptor-ligand
pairs could participate in signaling events which lead to reciprocal activation of both
cell types.
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concentrations (Alderson et al.t 1993) and recently CD40 has been reported on plastic
adherent monocytes/macrophages (Wagner et a t , 1994).
Monocytes do not constitutively synthesize IL-1, but as previously mentioned,
synthesis of IL-1 can be induced by exogenous triggering agents such as LPS. It has
been demonstrated that following LPS stimulation, IL-1 mRNA is rapidly transcribed
without further protein synthesis (Fenton et al., 1987). This suggests the presence of
preexisting transcription factors which become activated through a second messenger
system. It has been determined that there are two responsive regions in the IL-1 p
gene. The first identified region was the cap site-proximal region, just upstream of the
start codon (Fenton et al., 1987) and the second region which is much further upstream
is the LP5/PMA responsive region (Shirakawa et al., 1993). It was demonstrated that
mutations or deletions within either of these regions will prevent IL -lp
transcription/translation (Shirakawa et al., 1993).

Fenton et al., (1987) reported the

presence of elements including NF-pA, NF- kB, AP-1, and NF-IL6 in the cap siteproximal responsive region (-49 to -38). The presence of several enhancer elements
located in the LPS/PMA responsive region (positions -3307 to -2666), including four
cAMP responsive elements (CRE), three AP-1 sites, one NF-kB site and NFpA, an
element reported to be specific for the 1L-1B gene, likewise have been reported
(Shirakawa et al., 1993; Buras et al,, 1994). It was further suggested that the NF-pA
element confers tissue specificity for IL -lp (Buras et al., 1994).

Once the cell

receives an appropriate signal, any of the preexisting cytoplasmic transcription factors
may become activated, migrate to the nucleus and interact with the appropriate
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enhancer elements resulting in IL -lp induction. The activation of a particular factor(s)
would depend upon the specific signaling pathway employed by the cell contactmediated interactions between a ligand on activated T helper cells and its corresponding
receptor on macrophages. Many of the previously mentioned receptor - ligand
interactions could result in activation of various transcription factors.

CD40
A recently identified cell-contact dependent interaction that has proven to be
critical for Th induced B cell activation was CD40L:CD40 (Parker, 1993). When B
cell CD40 was blocked by antibody, Th dependent B cell activation was inhibited
(Noelle et al., 1992). Potentially this interaction could occur between activated T cells
and other APCs such as monocytes/macrophages, CD40 is a cell surface receptor
which is a member of the TNFo receptor superfamily. Other members o f this
superfamily include, NGFR (nerve growth factor receptor), CD27 (expressed on T
cells and B cells), CD30 (a T cell activation molecule), 0X 40 (an activated T cellantigen found only in rats), and Fas/Apo 1 (a T cell antigen that induces apoptosis)
(reviewed by Banchereau et al., 1994a]. The CD40 protein is a phosphoiylated
glycoprotein which has been reported thus far to be expressed on B cells, thymic
epithelial ceils, dendritic cells (Banchereau et al., 1994a) and very recently on human
monocytes (Alderson et al., 1993; Wagner et al., 1994). In B cell studies, crosslinking
of CD40 by anti-CD40 monoclonal antibodies induced proliferation of resting B cells,
and antibodies in combination with costimulating agents induced full activation of B
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cells (Clark and Ledbetter, 1986). Also, it has been shown that latex beads which
contain covalently attached anti-CD40 monoclonal antibody (Luxembourg and Cooper,
1994), or L-cells (a fibroblast cell line), transfected with the human Fey receptor, type
II, (FcyRII), then treated with monoclonal anti-CD40 antibodies (Larson and LcBien,
1994), induced B cells to a substantial proliferation response, further demonstrating the
effect of CD40 crosslinking on B cells. The importance of the CD40 signal in B cell
activation was reiterated since it was demonstrated that CD40 signals are required for
effective class switching. Cytokines including IL-4, IL-5 and IL-10, in combination
with an anti~CD40 monoclonal antibody or CD40L-fusion protein induced B cell
antibody production and class switching (Splawski et al., 1993; Grabstein et al., 1993;
and Banchereau et al., 1994b). Anti-CD40 antibodies or cytokines atone were
ineffective.
Sequence analysis o f the cDNA encoding human CD40 determined that the
primary structure is composed of 277 amino acids with a 193 amino acid extracellular
domain, a 22 amino acid transmembrane segment and a 62 amino acid intracellular tail
(Stamenkovic et al., 1989). The intracellular tail reportedly has no enzymatic activity
(Ren et al., 1994), therefore CD40 must associate with another protein such as a
protein kinase for signal transduction. It has been demonstrated that signal transduction
following CD40L or CD40 monoclonal antibody engagement of the CD40 molecule
induced phosphorylation of at least four distinct intracellular substrates in nonresting B
cells (Uckun et al., 1991). These authors showed that protein tyrosine kinase (PTK)
inhibitors, including herbimycin A and genistein, prevented phosphorylation of

11
intracellular substrates in B cells following stimulation through CD40. PTK inhibitors
have been shown to block B cell aggregation (Kansas and Tedder, 1991). The protein
kinase-C (PKC) inhibitor, H-7, was shown to abrogate the stimulation o f five
serine/threonine specific protein kinases, although the role of PKC during CD40 signal
transduction has not been defined (Uckun et al., 1991). Other recent studies have
shown that blockade of interaction between activated T cell plasma membranes (TmA )
and B cells via a CD40L monoclonal antibody prevented the phosphorylation of various
PTKs (Marshall et al., 1994). Contrary to earlier reports, it was demonstrated that
PKC was not involved in CD40 signaling in B cells (Marshall et al., 1994). TmA
interactions with B cells did not induce rises in intracellular Ca+I levels, cAMP
production, or PKC activity, effects which are mediated through the PKC pathway.
The ligand for CD40, CD40L (Armitage et al,, 1992) also known as gp39
(Noelle, et al., 1992), and T cell - B cell activation molecule [TBAM] (Lederman et
al., 1992), has been reported to be expressed on the cell surface of activated CD4+,
ThO, T hl and Th2, (Banchereau et al., 1994). CD40L has not been detected on CD8+
cells or on resting CD4+ cells but it has been reported that CD8+ cells activated by
lectins such as phytohemagglutinin (PHA) will express some CD40L (Roy et at.,
1993). The expression of CD40L is transient on activated CD4+ cells with maximal
expression reported to be at 6-8h post anti-CD3 activation and no detectable expression
was seen at 24h post anti-CD3 activation (Roy et al., 1993; Lederman et al., 1992).
This project was designed to demonstrate that the signals which induce IL-1
synthesis in monocytes/macrophages are communicated solely through cell-contact
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mediated interactions of activated Th cells with resting monocytes and that
CD40:CD40L interactions are critical for the induction of IL-1. Furthermore, we
examined the signaling mechanisms involved. Potential cell surface interactions
between macrophages and T cells which were examined included LFA-3:CD2, ICAM1:LFA-1, and B7/BBl:CD28/CTLA-4, and CD40:CD40L. Signal transduction
mechanisms involved in IL-1 induction were explored by looking at activation of
known transcription factors, specifically Nf-xB, which are specific for elements in the
IL-1 gene, and by use of drugs which block protein tyrosine kinases and protein kinaseC. Determination of the T cell-contact mediated interactions which are involved in the
induction of IL-1 synthesis and the subsequent signal transduction mechanisms could
lead to therapies which will better control inflammation.

C hapter 2
MATERIALS AND M ETHODS

Cell Preparation
Blood was collected from normal human volunteers and peripheral blood
leukocytes (PBL) were isolated over diatrizoate/Ficoll gradients (Ficoll-lite, Atlanta
Biologicals, Atlanta, GA). PBL's were plated at a density o f 5 x 106 cells per well in
24-well tissue culture plates (Falcon Primaria, Lincoln Park, NJ) in R P M I1640
(Hyclone, Logan, UT), containing 2 x 10'5M 2-mercaptoclhanol, lOOmM HEPES, and
gentamicin 50pg/ml, 5% FCS (henceforth designated as R-5), 100/rM EDTA.
Monocytes adhered to the plastic culture plates within 45 minutes and were isolated by
removal o f nonadherent cells. Adherent monocytes were rinsed twice with saline and
maintained overnight in R-5, lOOpM EDTA. Since monocytes are so responsive to
endotoxins, strict precautions were taken to ensure an endotoxin-free environment at all
times. All reagents used during cell culture and monocyte labeling, including
antibodies, were tested by chromogenic limulus assay (BioWhittaker, Walkersville,
MD) to determine endotoxin levels. Endotoxin levels of greater than 1 ng/ml were
considered unacceptable. When necessary, endotoxin was removed from reagents per
manufacturer's instructions with Acticlean-Etox (Sterogene Bioseparations Inc.,
Arcadia, CA).
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Antibodies
Anti-CD3 antibody was purified from culture supernatants of the hybridoma,
OKT-3, (Van Voorhis et al., 1983) from American Type Culture Collection, ATCC,
(Rockville, MD). The murine monoclonal IgM anti-human CD40, clone BL-C4,
produced by Monosan, (The Netherlands), was purchased from Caltag, (San Francisco,
CA). The monoclonal IgGl anti-human CD40 , G28-5, was a gift of Dr. E.A. Clark
(Dept, of Microbiology, University of Washington, Seattte WA).

Blockade

experiments utilized the monoclonal anti-CD40L, 5c8, a gift of Dr. Seth Lederman
(Columbia University, New York, NY) (Lederman et al., 1992). Anti-CD69, IgG l,
monoclonal antibody was purchased from Becton Dickinson (San Jose, CA).

IgM

isotype controls and goat anti-mouse IgG F(ab')2 were obtained from Southern
Biotechnology Associates, Inc., (Birmingham, AL). Horse radish peroxidase (HRP)
conjugated, goat F(ab')z anti-mouse IgM was purchased from Caltag Laboratories (San
Francisco, CA) and HRP-conjugated rabbit F(ab')2 anti-mouse IgG was from Southern
Biotechnology Associates, Inc. Anti-BB-1 (CD80), an IgGl monoclonal antibody,
anti-LFA-3 IgG2a monoclonal antibody, and anti-ICAM-1 IgG2b monoclonal antibody
were purchased from Camfolio division of Becton Dickinson (San Jose, CA).
Purification of CD4+ cell populations and immunoprecipitation experiments employed
monoclonal antibodies generated from hybridomas including anti-monocyte, 3C10
(IgG2b) (Hoffman e ta l., 1980), anti-B cell, LYM-1 (IgG2a), anti-NK, hNK-1 (IgM)
(Abo and Balch, 1981) and anti-CD8, OKT-8 (IgG2a) (Van Voorhis et al., 1983) and
anti-IL-lp (clone H6-A) (Kenney et al., 1987) all purchased from ATCC.

T Cell Purification and Activation
T cells were purified from the plastic-nonadherent cells on prewanned (37°C)
nylon-wool columns by incubating at 37 “C for 45 min. T lymphocytes were eluted off
the column with 25ml Dulbecco's phosphate buffered saline (DPBS) containing 2%
fetal bovine serum (FBS). The nylon wool purified T cells were either incubated in R5 (resting) or activated by plating on anti-CD3 coated plates. T cells were activated
for 3-18h at 37°C during kinetic studies and for 6h for other experiments.

Following

incubation, activated T cells were washed from the plates with DPBS, centrifuged and
resuspended in an appropriate medium, for either membrane preparation or
paraformaldehyde fixation. Cells were fixed by incubation in 1.0% paraformaldehyde
for 15 min at 4° C,

Fixed cells were then rinsed 3 times with PBS, resuspended in

PBS and incubated at 37“ C for 18h prior to use.
The CD4+ population was purified by magnetic panning. Plastic nonadherent
cells were incubated with monoclonal antibodies against cell surface molecules which
had been generated from hybridomas (described above) including 3C10 (monocytes),
LYM1 (B cells), anti-hNKl (natural killer cells), and anti-CD8 (CD8+ lymphocytes),
for 30 min on ice. The monoclonal antibodies were used as culture supernatants. Cells
were then treated with iron conjugated antibodies to murine IgG and IgM from
PerSeptives Diagnostics (Cambridge, MA) for 30 min with shaking at 4° C. Cells were
diluted to 1 x lOVml with sterile DPBS and the CD4‘ populations were removed via 27
megagauss Oerstead magnets (PerSeptives Diagnostics). A sample of the purified
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population was stained with F1TC conjugated anti-CD4 and analyzed by flow
cytometry. This population was typically found to be greater than 95% CD4+.

T Cell Membrane Preparation
Plasma membranes were prepared using a modification o f the method of Noelte,
et al., (1991). Briefly, resting and activated T cells, or transformed T cell lines
including D1.1(CD40L expressing T cell fine), HUT-78, or Jurkat (T cell leukemia cell
fine, CD40L') were resuspended in a hypotonic buffer containing 50mM Tris-HCL,
pH 7.4, 25mM KCI, 5mM MgClj, and proteinase inhibitors, phenyl methane sulfonyl
fluoride (PMSF) at 50pg/ml, leupeptin and pepstatin at lpg/ml for 30 min on ice. The
cells were then Dounce-homogenized until cells were completely disrupted as
determined microscopically. Disrupted cells were then centrifuged at 500xg for 5 min
to remove nuclei, then centrifuged at 95,000xg for 30 min in a Beckman L5-65
Ultracentrifuge. Cell debris was homogenized in 35% (wl/vol) sucrose/hypotonic
buffer then layered on 73 % (wt/vol) sucrose/hypotonic buffer. Hypotonic buffer was
layered on the 35% sucrose and the samples were centrifuged using a SW50.1 rotor at
130,000xg, for 2h to separate plasma membranes. The plasma membrane layer (at the
73%-35% interface) was collected and diluted 1:5 with hypotonic buffer, then
centrifuged again for 2h at 180,000xg to pellet membranes. The membrane pellet was
resuspended in PBS and total protein was determined by a microtiter plate protocol
based on the method of Lowry, et al., (1953) or by a microtiter plate protocol o f the
bicinchoninic acid (BCA) protein assay from Pierce (Rockford, IL). The BCA protein
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assay was read on a Biotek Instruments microtiter plate reader at 561nm. The microLowry assay was read on a Molecular Devices VMAX plate reader at 693nm.

Metabolic Labeling of Monocyte Proteins, Inununoprecipitatlon, and SDS
Electrophoresis of IL-1
The induction of IL-1 in monocytes by T cetts was measured by metabolically
labeling plastic adherent monocytes with 50/zCi 35S-methionine in methionine deficient
RPMI 1640 from Hyclone (Logan, UT) supplemented with 5/zg/ml insulin and
transferrin. After labeling, the culture medium was removed, cells were rinsed with
saline and lysed with an immunoprecipitation buffer containing 25mM Tris-HCl pH
7.4, 1% Triton X-100, 1% Deoxycholate, 0.35M NaCl, lOmM EDTA, and 50/xg/ml
PMSF. Lysed cells were immediately snap-frozen on dry ice and ethanol. Thawed
samples were immunoprecipitated with rabbit anti-human interleukin-IB (hIL -lp) or
anti-human IL-1 a from R&D Systems (Minneapolis, MN) as described previously
(Suttles et at., 1990). Monoclonal antibody against IL -lp, generated from the
hybridoma H-6A (Kenney et al., 1987), was used as culture supernatant fluid. The
precipitates were electrophoresed through 15% polyacrylamide gels. All gels included
14C-labeIed molecular weight markers including myosin at 205 killodaltons (kDa), pgalactosidase at 116kDa, bovine serum albumin at 66kDa, carbonic anhydrase at 29kDa
and lysozyme at 14,3kDa, obtained from Amersham International (Amersham, UK).
The gels were prepared for fluorography by soaking in autofluor from National
Diagnostics (Atlanta, GA) for Ih. Gels were then dried, and exposed to Kodak X-omat

LS X-ray film from Eastman Kodak Co (Rochester, NY). Autoradiographs were
quantified by image analysis using a Mitlipore Bioimage image analysis system.
Relative levels of IL-1 synthesis were evaluated based on the integrated optical density
(IOD), reported as OD/mm2 of labeled bands.

Flow Cytometric Analysis
For flow cytometric analysis of CD40 expression, adherent monocytes were
removed from tissue culture plates by incubation in PBS, 0.02% EDTA followed by
repeated pipetting. The cells were washed in PBS and resuspended in 100/xl of a 1:100
dilution of the monoclonal anti-CD40, G28-5 (IgGl) and incubated 30 min at 4°C.
The cells were washed, resuspended in an FITC-conjugated rabbit anti-mouse IgG
F(ab')2 and incubated for 30 min at 4°C, After a final wash in PBS the cells were
analyzed on a FACS* 420 with a Spectra-Physics 164-05 argon laser lasing at 488nm,
as described previously (Suttles, et al., 1986).

Cell-ELISA
Monocytes, selected by plastic adherence on 96 well plates, were fixed with
0.05% glutaraldehyde for 30 min. The cells were washed twice with saline, then
incubated in 10% horse serum, lOpg/ml human IgG in DPBS for 10 min for blockade
of nonspecific binding. The celts were again washed in saline, then incubated with
primary antibody suspended in the blocking solution. After washing, the cells were
incubated 30 min in a secondary antibody, horse radish peroxidase conjugated goat
anti-F(ab')2 from Southern Biotech (Birmingham, AL). Antibody binding was
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visualized by addition of peroxidase substrate tetramethyl benzidine dihydrochloride
from Sigma Chemical Co. (St. Louis, MO) Plates were analyzed on a Vmax model
microtiter plate reader from Molecular Devices (Menlo Park, CA) at 450nm.

Protein Kinase Inhibitors
Inhibitors of signal transduction included herbimycin A and genistein, potent
PTK inhibitors, staurosporine, an inhibitor of phospholipid/calcium dependent protein
kinase activity and H-7, a protein kinase-c inhibitor. Herbimycin A was obtained from
Calbiochem (La Jolla, CA), resuspended in DMSO and used at concentrations ranging
from 0.01/xg/ml to 1.0/ig/ml. Staurosporine, Sigma Chemical Co. (St. Louis, MO),
was resuspended in DMSO at Img/ml, and used at concentrations ranging from lng/ml
- lOOng/ml. H-7 and an H-7 analog, l-(5-isoquinolinylsulfonyl-3-methylpiperazine,
(Sigma Chemical Co.), were rcsuspended in water and used at concentrations ranging
from 1.0/jg/mI - 10/ig/ml. Genistein, (Sigma Chemical Co.), was resuspended in
lOOmM DMSO and used over the range of O.lpg/ml - lOpg/ml.

Electrophoretic Mobility Shift Assays
THP-1, a human monocytic cell line, was cultured in RPMI, supplemented with

5 % FBS and for experiments, celts were transferred to 6-well multiwell plates at a
concentration of 5xl07/ml. THP-1 or peripheral monocytes at 2-5xl07 were left as
unstimulated or stimulated with LPS at 1/ig/ml, or BC-L4, anti-CD40 IgM, at lpg/m l.
Cells were collected and lysed to isolate nuclei based on the method of Buras et al.,
(1994). Briefly, celts were lysed in hypotonic buffer containing lOmM KCI, 0.3M
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sucrose, lOmM p-glycerol phosphate, 0.2mM EGTA, 0.4% nonidet P-40, lmM PMSF
and 1/ig/ml each of leupeptin and pepstatin, on ice for 30 min with intermittent gentle
agitation. Following lysis, nuclei were collected by centrifugation at 1 l,500g for 5
min. Nuclear proteins were extracted by incubating nuclei in a buffer containing 25%
glycerol, 1.5mM MgCI2, 0.2mM EDTA, 0.5mM dithiothreitol, lmM PMSF and
1/tg/ml each of leupeptin and pepstatin, and 0.4M KCI for 30 min on ice. Extracts
were centrifuged at ll,5 0 0 g and supernatants were collected as nuclear extracts.
Extracts were concentrated and reconstituted to 0.1M KCI using Microcon
microconcentrators from Amicon (Beverly, MA). Protein determinations were done by
the BCA micro protein assay. Extracts were aliquoted and frozen at -80° C.
Binding assays were done using oligonucleotides, which included the binding
elements for NF- kB from Promega Corp. (Madison, WI). Nf-xB elements were endlabelled with 31P-gamma ATP (ICN Biomedicals Inc., Irvine, CA). Nuclear extracts
were incubated with gel shift binding buffer (4% glycerol, lmM MgCl2i O.SmmM
EDTA, 0.5mM DTT, 50mM NaCI, lOmM Tris, pH 7.5, 0,05mg/ml salmon sperm
DNA), and 31P-oligonucleotides at approximately 5x10s cpm. Binding reactions were
done at room temperature for 30 min. Cold competition assays were done by first
adding unlabelled oligonucleotides, 3.5pmoles, incubating for 20 min, then adding 32Plabelled oligonucleotides. Following binding reactions, samples were prepared for
electrophoresis by addition of lOx gel loading buffer (250mM Tris, pH 7.5, 0.2%
bromphenol blue, 0.2% xylene cyanol and 40% glycerol). Samples were loaded onto
4% polyacrylamide gels which had been prerun for lh at 100V constant voltage, and
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electrophoresed at 100V constant voltage until the bromphenol blue dye front reached
the bottom of the gel. Following electrophoresis, gels were dried onto Whatman filter
paper and exposed to x-ray film overnight at room temperature.

Chapter 3
RESULTS

Membrane Determinants on Activated, But Not on Resting T Cells Induce Resting
Monocytes to Synthesize IL-lp
It has previously been demonstrated that contact-dependent signals induce
macrophage effector function (Stout and Suttles, 1992; Stout and Suttles, 1993; Tao
and Stout, 1993). Following this line of investigation, experiments were designed to
test whether plasma membranes from activated peripheral T cells could induce IL-1
protein synthesis by monocytes obtained from the same individual, through contactdependent interactions alone. Peripheral T cells were activated on anti-CD3 coated
plates for 5 hours and plasma membranes prepared from the activated T cells (TmA)
were compared to plasma membranes from resting peripheral T cells (TmR) for their
ability to induce IL -lp synthesis in resting, adherent monocytes. IL-1 synthesis was
monitored by metabolic labeling using 3SS-labelled methionine and immunoprecipitation
of monocyte cell lysates with anti-IL-1 antibodies. TmAsuccessfully induced IL -lp
synthesis (Figure 2), whereas TmR at the same concentration (25pg/ml) did not induce
IL -lp synthesis above background. The ability of TmA to activate monocytes was
titrated across a range o f 10-25/xg/ml, resulting in a dose-dependent response. These
results suggest that activated T cells can provide all the necessary costimulatory
molecules through cell surface interactions alone, to induce monocytes to synthesize IL1P.
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Figure 2. Activated T cell plasma membranes (TmA) but not resting T cell plasma
membranes (TmR) induce human monocyte IL -lp synthesis.
Plastic adherent monocytes were incubated with either TmAor TmR for 5h in the
presence of 50/iCi MS-methionine. Cell lysates were harvested, immunoprecipitated
with anti-IL-lp monoclonal antibody, and etectropboresed on SDS-polyacrylamide
gels. Proteins were visualized by autoradiography. The arrow indicates precursor ILlp , 33kDa. Lane 1, unstimulated controls; Lane 2, LPS at 10/ig/ml; Lane 3, TmA at
25/xg/ml; and Lane 4, TmR at 25/jg/ml,
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Kinetics of T cell expression of monocyte activating determinants
Having demonstrated that TmA are capable o f inducing monocytes to synthesize
IL -lp through contact-dependent interactions alone, it was of interest to determine the
expression kinetics of the T ceil surface molecules which induced IL -lp synthesis. The
kinetic studies were performed using purified CD4+ cells which were
paraformaldehyde fixed post-activation. Plastic adherent monocytes were incubated
with the same number of either fixed resting CD4+ cells, (Oh), or CD4+ cells that had
been activated on immobilized anti-CD3 for 3h, 6h, or 18h. As shown in Figure 3,
CD4+ cells stimulated for 6h were most effective in the induction o f monocyte IL -lp
production. Image analysis of the 33 kDa IL-1 p precursor bands reported an integrated
optical density, (IOD) (density/mm2) o f 8.25 at 6h as compared to an IOD of 0.25 at
Oh, an IOD of 3.46 at 3h, and an IOD of 2.41 at 18h. This suggested that maximal
expression of the determinants on activated T cell surfaces which induce IL-1 synthesis
in monocytes occurred at 6h post activation.

Expression and Upregulation of Monocyte CD40
Any of a number of activation-induced cell surface proteins could be considered
as likely candidates for T cel 1-monocyte signaling. However, given the correlation of
the expression kinetics of the IL-1 activating signal with those of expression of T cell
CD40L (optimal at 6h) (Lederman et al., 1992), the possibility that CD40L may be
contributing to the monocyte response was explored. First, the level of expression of
CD40 on resting adherent monocytes was analyzed by flow cytometry to assess the
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Figure 3. Kinetics of expression of T cell IL-l-inducing de term inant (s).
Monocytes, at 5x10s, were incubated with CD4+ cells which had been left as
resting (Oh), or had been incubated on anti-CD3 coated plates for 3h, 6h, or 18h prior
to immediate paraformaldehyde fixation. Fixed CD4+ cells were added to monocytes
at 4 x 10s cells/ml and incubated for 4h in the presence of 3JS-methionine. Lysates
were harvested, immunoprccipitated, and run on SDS polyacrylamide gels. The times
designated above each lane indicate the length of time of anti-CD3 activation of the T
cells. Data is representative of four experiments. The arrow indicates the 33kDa
precursor, intracellular form o f IL -lp.
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feasibility of a potential CD40-CD40L interaction in IL-1 induction. Adherent
monocytes were removed from tissue culture plates and labeled with the monoclonal
anti-CD40 antibody, G28-5, followed by FITC-conjugated rabbit anti-mouse IgG
F (ab % Flow cytometry revealed that resting plastic adherent monocytes exhibited
significant expression o f CD40 (mean fluorescence of 150) as compared to the IgGl
isotype control (mean fluorescence 15) (Figure 4a). Expression of CD40 could be
upregulated slightly with either IFNy or LPS, and to greater extent by treatment with
the combination of both LPS and IFNy (mean fluorescence 300). Analysis of
expression using cell-EUSA demonstrated that TmA, but not TmR could also upregulate
CD40 expression over 50% above the expression levels of unstimulated cells (Figure
4b). The cell-ELISA experiments confirmed that the combination of LPS and IFN y
substantially upregulated CD40 expression on adherent monocytes (Figure 4b), as
initially demonstrated by flow cytometry. The analysis of CD40 expression suggested
that resting adherent monocytes are capable of receiving signals from activated T cells
through a CD40L-CD40 interaction, and that the contact-dependent interaction results
in the upregulation of CD40 expression. Once it had been determined that interaction
between CD40L on activated T cells and CD40 on monocytes was feasible,
experiments were designed to block the interaction using antibodies to CD40L, and
determine the result on IL -lp production in monocytes/macrophages.

Blockade o f T cell m em brane signaling with anti-CD40L antibodies
To directly address whether interaction between CD40L on activated T cells
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Figure 4. Expression of CD40 on plastic adherent human monocytes.
(A). Analysis o f CD40 expression by flow cytometry. Monocytes at lx l0 6/ml
were left unstimulatcd or stimulated with IFNy at lOOU/ml, LPS at lOjtg/ml, or IFNy
(100U/ml) plus LPS (10/ig/ml) for 18h.

Monocytes were incubated with G28-5, at

1:100 followed by an FITC-conjugated goat F(ab')2 anti-murinc IgG and analyzed by
flow cytometry. Isotype control labeling is seen as the dotted line. The profile of antiCD40 labeled is represented by the solid line.
(B). Analysis o f CD40 expression by cell-ELISA.
Adherent monocytes at 5x10* were incubated in the presence or absence o f LPS +IFN y,
TmR or TmAlabeled using cell-ELISA with anti-CD40 (G28.5) followed by horse
radish peroxidase conjugated goat anti-F(ab')2.
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and CD40 on monocytes induces IL-1, the ability of the monoclonal anti-CD40L (TBAM) antibody, 5c8 (Lederman et al., 1992), to interfere with the ability of TmAor
activated, fixed CD4+ cells to induce monocyte IL-1 synthesis was tested. Activated
peripheral CD4+ cells were fixed with paraformaldehyde and added to resting
monocytes in the presence or absence of the 5c8 antibody. The antibody, 5c8, was
titrated in these experiments over a concentration range of 1-25/ig/ml. Control groups
included fixed activated CD4+ cells alone, and fixed activated CD4+ cells incubated
with an IgG2a isotype control. Throughout experiments, addition of 5c8 blocked signal
transduction by activated CD4+ cells in a dose-dependent fashion as depicted in Figure
5. Data obtained through image analysis revealed an 85% reduction in IL-lp synthesis
with the addition of 25/ig/ml 5c8. A 50% reduction in signal was observed at an
antibody concentration o f 10/zg/mt and a 30% reduction at lpg/m l. Addition of an
IgG2a isotype control at the same concentrations had no inhibitory effect on the ability
of activated, fixed CD4+ cells to stimulate monocyte IL -lp synthesis . In initial
studies to block the ability of activated T cells to induce monocyte IL-1 synthesis, other
monoclonal antibodies were tested. Anti-ICAM-1, anti-CD80 (BB-1), and anti-LFA-3
were not effective at concentrations tested, in blocking the activated T cell signal for
IL-1 synthesis. Also in separate experiments, none of these antibodies alone were
agonistic towards IL-1 induction. The choice of these antibodies was based on previous
demonstrations that the cell-surface molecules which these antibodies recognize are
present on monocyte/macrophage cell surface, and that they may play some role in B
cell signaling. These data suggest that ICAM-1, CD80 and LFA-3 interactions do not
play a substantial role in the signaling of monocyte IL-1 synthesis.
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Figure 5. Anti-CD40L (5c8) blockade o f contact-dependent CD4+ induction of
monocyte IL -lp synthesis.
Monocytes were incubated with 1 x lO^cells/ml anti-CD3 activated fixed CD 4+
celts in the presence or absence of 5c8 at 1, 10 and 25/ig/ml. The cells were
metabolically labeled for a 4h incubation. Lane 1, monocytes incubated with fixed
resting CD4+ cells alone; Lane 2, monocytes incubated with fixed activated CD4+
cells; Lane 3, monocytes incubated with fixed activated CD4+ cells plus 5c8 at
25pg/ntl; Lane 4, monocytes incubated with activated CD4+ cells plus 5c8 at 10pg/ml;
Lane 5, monocytes incubated with activated CD4+ cells plus 5c8 at 1/ig/ml. Data is
representative of three experiments. Arrow indicates 33kDa intracellular form o f IL1P.
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Anti-CD40 Stimulation of Monocyte IL-1 Synthesis
In addition to the blockade studies, anti-CD40 antibodies were used to examine
signals mediated through CD40 which may lead to IL-1 induction. Studies of B celt
signaling have employed the IgGl monoclonal anti-CD40 antibody, G28-5, to mimic
the CD40L binding event. G28-5 has been found to stimulate B cell responses,
selectively, when accompanied by costimulatory cytokines (Armitage et al., 1992, and
Splawski, et al., 1993). G28-5 was not capable of stimulating monocyte IL-1
production over a broad range of concentrations, i.e. from 1/ig/ml to 25/ig/ml.
However, the IgM monoclonal anti-CD40, BL-C4 proved to be a potent stimulus of
both IL -lp and IL -la production (Figure 6, a and b). BL-C4 was tested at
concentrations ranging from 0 .1/ig/ml to 10/ig/ml and was found to induce IL-1
synthesis in a dose dependent fashion . It was speculated that the ability of BL-C4, but
not G28-5, to induce IL-1 may be due to the ability of pentameric IgM to crosslink
CD40. The enhancement o f B cell CD40 signaling through crosslinking has been
observed previously (Clark and Ledbetter, 1986; Luxembourg and Cooper, 1994;
Larson and LeBien, 1994). Experiments therefore were designed to examine the
efficacy of crosslinking CD40 on monocytes. Plastic adherent monocytes were
incubated with G28-5 followed by goat F(ab')2 anti-murine IgG. Crosslinking G28-5
with goat F(ab')2 anti-mouse IgG successfully induced IL -lp synthesis (Figure 7)
whereas neither F(ab')2 anti-mouse IgG nor G28-5, alone, had any effect. The effects
o f crosslinking on induction of IL -la synthesis were not examined. These results
suggest that crosslinking of CD40 receptors may be a requirement for efficient

Figure 6. Stimulation of monocyte IL-1 synthesis with anti-CD40 antibodies.
Monocytes were incubated with BL-C4 during a 4h metabolic protein labeling
period. Cell lysates were harvested and immunoprecipitated with anti-IL-lp (panel A)
or anti-IL-la (panel B). The arrows identify the IL -lp and IL -la 33kDa precursor
proteins. Panel A, induction o f IL -lp synthesis: Lane 1, unstimulated monocytes;
Lane 2, LPS at 10/ig/ml; Lane 3, IgM isotype control at 1/ig/ml; and Lane 4, BL-C4 at
1/ig/ml. Panel B, induction of IL -la: Lane 1, unstimulated monocytes; Lane 2, LPS
at 10/ig/mI; Lane 3, IgM isotype control at 1/ig/ml; and Lane 4, BL-C4 at 1/ig/ml.
Bands seen below the arrow are 25kDa processing intermediates of IL -lp which has
been reported previously (Suttles et al., 1990).
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Figure 7. Requirement for crosslinking of monocyte CD40 for IL -lp induction.
Monocytes were incubated with G28-5 at 25/ig/ml for 20 min. An F(ab’)2 anti
murine IgG was added at 15pg/ml during a 4h metabolic protein labeling incubation.
Cell lysates were harvested and immunoprecipitated with anti-IL-lp. Lane 1, G28-5,
alone, at 25pg/ml; Lane 2 F(ab')2, alone, at 15pg/mt; Lane 3, G28-5, 25/jg/ml
followed by F(ab')2 15/ig/ml. Arrow indicates the 33kDa precursor form of IL -lp.
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signaling in monocytes, as has been demonstrated in studies o f B cell CD40 signaling.
The specificity of effect of BL-C4 was evaluated by blockade experiments using G28-5.
Since the G28-5 antibody bound to CD40 on monocytes, but did not initiate IL-lp
synthesis, the ability o f G28-5 to inhibit BL-C4 activation was examined.

Plastic

adherent monocytes were pre-incubated with G28-5 prior to BL-C4 stimulation. Pre
incubation of the monocytes with lOpg/mi G28-5 inhibited BL-C4 stimulus o f IL-lp
production by 77% as determined by image analysis of the autoradiograph (Figure 8).

Requirement of Costimulatory Signals In Addition to CD40
Experiments using TmAto activate resting, plastic adherent monocytes clearly
demonstrated that all the signaling requirements for the induction of monocyte IL-1
synthesis are found on the activated T cell surface as demonstrated in Figure 1. As
another means of examining the contribution of CD40L towards the induction of IL-1
in monocytes/macrophages, experiments were designed to test whether a human T cell
leukemia line, D l . l , which constitutively expresses CD40L (Yellin et al.t 1991), or a
cell line transfected with a CD40LcDNA, 293/CD40L+, could induce IL-1 synthesis
through cognitive signals. Plasma membranes were generated from D l .l,
293/CD40L+ and from a control parent line, Jurkat B2.7, which does not express
CD40L (Yellin et al., 1991). D l.l or 293/CD40L+, or Jurkatt plasma membranes
were incubated with monocytes in metabolic labeling experiments at amounts
equivalent to TmA that induced substantial IL-1 synthesis (25pg/ml), as demonstrated in
Figure 1. However, de novo synthesis of IL-1 was not detected. This result was
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Figure 8. Blockade of BL-C4 induction of IL -lp with G28-5.
Monocytes were stimulated with BL-C4 either alone, or after a 20 min
pretreatment with G28-5, for a 4h labeling incubation. Cell lysates were
immunoprecipitated with anti-IL-lp. Lane 1, G28-5, alone, at 25pg/ml; Lane 2, BLC4, alone at 1/ig/ml; Lane 3, G28-5 at 25/ig/m! (pre-incubated 20 min) plus BL-C4 at
lpg/m l. Arrow indicates the 33kDa precursor form of IL -lp,
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surprising since experiments demonstrated that direct blockade o f CD40L:CD40
strongly diminished TmA's ability to induce IL -lp in monocytes, and experiments
utilizing monoclonal IgM anti-CD40 antibodies were successful at inducing IL-1
synthesis. Combinations of membranes including D l .l with B2.7, and D l .l with TmR
also did not induce IL-1 synthesis. These findings suggest that a costimulatory
molecule in addition to CD40 on monocytes is required for cell-contact mediated
induction of IL-1 and that the required costimulatory molecule is unique to the
activated T cell surface.
It has been demonstrated that a T cell line, HUT-78, once activated, can induce
IL-1 synthesis in THP-1, a monocytic cell line, through cell-contact dependent signals
(Dayer et al., 1993). These authors demonstrated that an anti-CD69 monoclonal
antibody was able to partially block the signal. It is possible therefore, that CD69 may
provide the costimulus required for induction of IL-1 synthesis in monocytes.
Experiments were designed to test this hypothesis. It was determined by flow
cytometry analysis that D l.l cells do not express CD69 (Figure 9), and that
unactivated HUT-78 express only low levels of CD40L (Figure 9). Therefore
monocytes were metabolically labeled in the presence of D1.1(CD40L+, CD69') and
HUT-78(CD69+, CD40L10) plasma membranes. As controls, monocytes were
incubated with either D l .l or HUT-78 membranes alone. The combination of plasma
membranes was synergistic towards induction of IL -lp synthesis in monocytes (Figure
10). Image analysis revealed that the combination o f membranes (I.O.D, - 6.52) was
20 times more effective at inducing IL-lp synthesis than the HUT-78 (I.O.D. = 0.322)

Figure 9. Expression of CD69 on D l .l cells and expression of CD40L on HUT-78
cells.
D l.l cells, lxlOVmf, were treated with an IgG anti-CD69 monoclonal
antibody. Cells were then stained with a FITC-conjugated goat F(ab')2 anti-murine
IgG. Flow cytometry was performed as described in Materials and Methods. A
negative control, second antibody alone, was included (dotted lines). The profile of
anti-CDG9 stained cells is indicated by solid lines.
IIUT-78 cells, lxlO6, were treated with the anti-CD40L monoclonal antibody,
5c8, and stained with a FITC-conjugated goat F(ab')2 anti-murine IgG. Flow
cytometry was performed as described in Materials and Methods. Negative controls
(dotted lines) were second antibody alone. The profile of CD40L expression is seen as
solid lines.
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Figure 10. HUT-78 plasma membranes in combination with D l. 1 plasma membranes
induce IL -lp synthesis in monocytes.
Monocytes were plastic adhered and incubated with plasma membranes from
HUT-78 (CD40L10 , CD69+ ), D l.l (CD40L+, CD69' ) or a combination o f the two
membranes. Following metabolic protein labeling with 35S-Methonine, cell lysates
were immunoprecipitated as described in Materials and Methods. Lane 1, anti-CD40 at
l^g/m l; lane 2, D l .l plasma membranes at 15^g/ml; lane 3, D l .l (15/ig/ml) + HUT78 (15/xg/ml) membranes; lane 4, HUT-78 plasma membranes at 15/ig/ml . Arrow
indicates 33kDa precursor form o f IL -lp .
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membranes alone and 100 times more effective than D l.l (I.O.D. = 0.065) alone.
Low level induction by the HUT-78 may be due to the low levels of CD40L on the cell
surface. This data suggests that CD69 may indeed play a contributory role in the T cell
contact-mediated induction of monocyte IL-lp synthesis.

Effects of Protein Tyrosine Kinase Inhibitors and Protein Kinase-C Inhibitors on
Monocyte IL-lp Production
To evaluate the signal transduction events induced in monocytes through CD40
signaling, monocytes were pretreated with a variety of known signal transduction
inhibitors prior to stimulation with the BL-C4, the IgM anti-CD40 antibody. Inhibitors
of protein tyrosine kinase (PTK) regulated pathways and protein-kinase C (PKC)
regulated pathways were tested at a variety of concentrations. Herbimycin-A has been
described as a potent inhibitor of PTKs (Uckun et al,, 1991; Weinstein et al,t 1992;
and Deans et al., 1993). While several PTKs have been identified from a variety of cell
types, the specificity o f herbimycin-A beyond that of a general PTK inhibitor has not
been elucidated. The effects of H-7 and staurosporine, PKC pathway inhibitors
(Uckun et al., 1991), were also examined. In initial experiments, the effects o f various
concentrations o f the inhibitors on total cellular protein concentration and the effects of
the inhibitors on preventing de novo protein synthesis were tested. At all
concentrations tested there was no difference between total cellular protein levels as
determined by BCA protein analysis (Table 1). There were, however, substantial
effects on de novo protein synthesis (Figure 11). For example herbimycin-A at 1/ig/ml
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TABLE 1
The Effects of Protein Kinase Inhibitors on Monocyte Total Cellular Protein
T reatm ent

BCA Protein in /ig

untreated

7.86

LPS

7.58

anti-CD40

8.08

PKC Inhibitors:
Staurosporine lOOng/ml
Staurosporine lOng/ml

7.36

Staurosporine lng/ml

7.47

H-7 10/ig/ml

7.64

H-7 1/ig/ml

7.03

H-7 (3Me) 10/ig/ml

7.42

PTK Inhibitor:

7.64

Herbimycin-A 1/ig/ml
Herbimycin-A 0 .1/ig/ml

8.02

Herbimycin-A 0 ,0 1/ig/ml

7.74
8.13

Mean = 7.664
s.d. = 0.324

Table 1. Cells were plated at 5x10s /ml and pretreated with herbimycin-A ,
staurosporine, H-7, or the H-7 analog, H-7(3Me) for 18h. Protein analysis was done
on total cell lysates using a BCA-protein assay kit as described in Materials and
Methods.
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Figure 11. Effects o f protein kinase inhibitors on monocyte total de novo protein
synthesis.
Monocytes were preincubated with herbimycin-A , staurosporine , H-7 or an
H-7 analog, H-7[3-Me], for 18h. Cells were then stimulated with anti-CD40 IgM at
1/ig/ml during 3iS-methionine metabolic labeling experiments for 4h. Samples of total
cell protein were electrophoresed through SDS-polyacrylamide gels and visulaized by
autoradiography. Lane 1, untreated; lane 2, LPS at 10/ig/ml; lane 3, anti-CD40
(1/ig/ml) alone; lane 4, staurosporine at lOOng/mt; lane 5, staurosporine at lOng/ml;
lane 6, staurosporine at Ing/ml; lane 7, H-7 at 10/ig/ml; lane 8, H-7 at 1/tg/ml; lane 9,
H-7(3Me) at 10/ig/ml; lane 10, herbimycin-A at 1/ig/ml; lane 11, herbimycin-A at
0.1/tg/ml; lane 12, herbimycin-A at 0.01/ig/ml.

1

2

3

4

5

6

7

8

9

10

11

12

41
Figure 12. Effects of protein kinase inhibitors on IL -lp induction.
Monocytes were preincubated with herbimycin-A, staurosporine, H-7 or an H-7
analog, H-7[3-Me], for 18h. Cells were then stimulated with anti-CD40 IgM at
1/ig/ml during 35S-methionine metabolic labeling experiments for 4h. Cell lysates were
immunoprecipitated with the monoclonal anti-IL-lp antibody.

Lane 1, untreated; lane

2, anti-CD40 at 1/ig/ml; lane 3, herbimycin-A at 0 .1/ig/ml; lane 4, H-7 at 1/zg/ml;
lane 5, staurosporine at lOng/ml. Arrow indicates 33kDa precursor form o f IL -lp.
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prevented total de novo protein synthesis but at 0 .1/ig/ml, herbimycin-A had no
appreciable effect on synthesis (Figure 11). But at 0.1/ig/ml, herbimycin-A
substantially reduced IL -lp production (Figure 12). At concentrations which did not
abolish total de novo protein synthesis, H-7 had very little effect on IL -lp synthesis
(Figure 12). Staurosporine, likewise did not effect IL-1 synthesis at concentrations
which did not abolish total protein synthesis. In fact, both H-7 and staurosporine
apparently had activating effects on anti-CD40 IgM induced IL -lp production (Figure
12). It has been reported that PKC inhibitors enhance PTK activity (Mufson et al.,
1992; and Shapira et al., 1993). These data suggest that signaling through CD40 may
primarily utilize a protein tyrosine kinase regulated pathway and that PKC pathways
apparently are not involved in signaling through CD40. It has been reported in B cell
systems that plasma membranes from activated T cells induced PTK activities but did
not increase cAMP, calcium, or PKC activity (Marshall et al., 1994). These authors
also reported that an anti-CD40L monoclonal antibody, 5c8, could reduce PTK
induction in B cells. The data presented here correlate with the finding that B cell
signaling through CD40 induces PTKs but not PKC activity.

Transcription Factors Activated Through CD40 Signaling
In addition to the signal transduction information gained by using inhibitors to
intracellular pathways, experiments were done to determine if the transcription factor,
NF-xB would be activated through CD40 signaling. It has been demonstrated that NFkB

is activated in monocytes through LPS signaling (Drouet et al., 1991). For initial

experiments, THP-1, a premonocytic cell line was used. It was determined by flow
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cytometry that THP-1 cells conslitutively express CD40, and can be induced to
synthesize IL -lp by treatment with IgM anti-CD40 (BL-C4). Therefore, THP-1 were
stimulated with BL-C4 for 4S min and nuclear extracts were prepared. Electrophoretic
mobility shift assays (EMSA) demonstrated that CD40 signaling induced activation of
NF- kB or an NF-kB like protein (Figure 13). Competition assays using unlabeled
DNA oligonucleotides which bind NF- kB, were performed to verify that the bands
indicated were NF-kB. Two band shifts were identified (Figure 13). NF- kB is
composed o f two protein subunits, p65 and p50, which form both heterodimers and
homodimers (Moore et al., 1993).

Moore et al (1993) reported that the heterodimer is

the predominant form o f NF-kB and the pbSsubunit constitutes the primary
homodimeric form. The two band shifts observed in Figure 13 may correspond to the
homodimer and hcterodimer forms but supershift assays using antibodies specific for
p65 and p50 would be required to make such a determination. It was apparent that
THP-1 constitutively activate 1 form of Nf-xB (Lane 1, Figure 13), which is consistent
with reports in B cell studies (Lalmanach-Girard et al., 1994). It has been reported that
NF- kB binding elements are present in the IL -lp gene enhancer region (Fenton et al.,
1987; Zhang and Rom, 1993; Hunninghake et al., 1992). These data suggest that
signaling through CD40 activates NF- kB in the premonocytic cell line, THP-1, which
appears to be a suitable model for studying activation of transcription factors
through CD40 signaling.

Effects o f CD40 Signaling on The Expression of Monocyte Cell Surface Molecules
Several costimulatory/adhesion molecules including ICAM-l/ICAM-2 (Springer,
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Figure 13. Activation o f NF-xB in THP-1 cells through CD40 signaling.
THP-1, a premonocytic cell line, were plated at 2.5xl07 cells and treated with
anti-CD40 IgM at lpg/m l. Nuclear extracts were prepared and incubated with 32Plabeled NF-xB binding oligonucleotides. Samples were electrophoresed through 4%
polyacrylamide gels to generate electrophoretic mobility shift assays. Lane 1, untreated
cells; lane 2, LPS at 10/ig/ml; lane 3, LPS + unlabelled NF-xB in molar excess,
1.75pmoles (cold competition for LPS activation); lane 4, IgM anti-CD40; lane 5, IgM
anti-CD40 + unlabelled NF-xB molar excess (cold competition for anti-CD40
activation). Arrows indicate band shifts.
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1990), LFA-3 (Webb et al., 1990), B-7 (Freedman et al., 1991) and recently CD40
(Alderson et al., 1993, and Wagner et al., 1994) have been demonstrated on the cell
surface of monocytes/macrophages. Experiments were designed to determine how T
cell contact-dependent signals can regulate the expression o f these cell surface
molecules. Peripheral monocytes were plated on 96-well plates and stimulated with
paraformaldehyde fixed activated T cells or paraformaldehyde fixed resting T cells,
LPS, IFNy, or with anti-CD40 IgM. Fixed, activated T cells and anti-CD40 IgM
substantially upregulated the expression of ICAM-1, whereas resting T cells had a
slight upregulatory effect as demonstrated by cell-ELJSA assays (Table 2). This
suggests that anti-CD40 signals, and signals provided through contact-dependent
interactions with activated T cells upregulates ICAM-1. LFA-3 expression was not
affected by anti-CD40, compared to isotype controls, but was upregulated by fixed,
activated T cells (Table 2), while fixed resting T cells had no appreciable effect (Table
2). It has recently been reported that stimulation through CD40 upregulates the
expression o f CD80 (BB-1) on B cells (Vellin, et al., 1994). The expression of CD80
(BB-1) was not altered by anti-CD40 stimulation or by fixed resting T cells compared
to isotype controls. CD80 was upregulated two-fold by fixed, activated T cells.
These data suggest that contact-dependent interactions between adherent
monocytes and activated T cells lead to up regulation of monocytic cell surface
molecules including ICAM-1, LFA-3 and CD80 (BB-1). Additionally, it appears that
CD40 signaling substantially upregulated the expression of ICAM-1. Unlike reports in
B cells (Yellin et al., 1994), CD40 signaling did not upregulate the expression of CD80
(BB-1) in these experiments.

TABLE 2
Regulation of Expression of Cell Surface Molecules on Adherent Monocytes
Cell
Surface
Molecule

unstimulated

LPS

IF N Y

TR

TA

a-CD40

Isotype

CD80

7.2±1.5*

7.2 ± 0 .6

7.2± 0.5

7 .8 ± 0 .7

16.0±1.9

9.7± 0.9

9.1 ± 1 .0

ICAM-1

17.3 ±2.3

n.d.

n.d.

23.0± 0.2

57.3 ± 2 .2

44.1 ± 4 .0

9 .8 ± 1 .0

LFA-3

9.5 ±1.6

11.1 ± 0.3

12.4 ±1.3

10.1 ± 0 .7

17.4±2.6

10.9±0.7

9 .1 ± 1 .0

•Values reported are arithmetic means ±standard errors xlO'2 of optical density units and representative o f three experiments
Table 2. Peripheral blood mononuclear cells were plated at 5x10s cells/well. Adherent cells were stained with the appropriate
antibody at 1:100 (lOpg/ml). Cells were rinsed to remove unbound antibody, and incubated with an HRP-conjugated second
antibody [HRP-(Fab')J. TA were activated for 6h. Cell-EUSAs were performed as described in Materials and Methods. Optical
densities were determined using a Vmax plate reader,
n.d. = not done.

C hapter 4
DISCUSSION

The induction o f a successful immune response is dependent upon the formation
of physical conjugates between T helper (Th) cells and antigen presenting cells (APCs).
The intent of this study was to define interactions during physical conjugate formation
between monocytes and T cells, which result in activation of monocyte/macrophage IL1 production. The initial interaction between T cells and monocytes/macrophages is
antigen-dependent, and MHC-II restricted. Signals, both cell-contact mediated and
cytokine mediated lead to reciprocal activation. Previous studies have demonstrated
that paraformaldehyde fixed, activated T cells in the presence of IFNy can induce nitric
oxide and IFNp production in monocytes/macrophages (Tao and Stout, 1993). These
effector functions of monocytes/macrophages require a TNFo autocrine loop, and it has
been demonstrated that activated T cells will induce transcription of TNFa message as
well as protein synthesis and secretion (Stout, 1993; Stout and Suttles, 1992; and
Suttlcs et al., 1994). Since fixed, activated T cells transduced the appropriate signals,
cell-contact mediated signals alone were sufficient to induce TN Fa message/protein
production in monocytes/macrophages. This study has extended these earlier studies by
identifying molecules involved in the contact-dependent T helper
cell:monocyte/macrophage signal. Purified plasma membranes from activated, but not
resting CD4+ T cells, or fixed activated cells, were capable o f inducing monocyte IL-1
synthesis. The activating determinant(s) on the T cells are expressed optimally at 6h

47

48
post anti-CD3 activation, a kinetic profile which matches that of the expression of the
CD40 ligand (Lederman et al,, 1992). These data, and the observed expression of
CD40 on adherent resting monocytes provided circumstantial evidence implicating
CD40 as a candidate for the T cell-mediated IL-1 signaling event. The demonstration
that 5c8, a monoclonal anti-CD40L (T-BAM) can effectively block the ability of fixed
activated CD4+ cells to induce monocyte IL-1 synthesis (Figure 5) provided definitive
evidence of the role o f CD40-CD40L signaling in T cell-monocyte interactions.
The CD40-CD40L interaction has been studied extensively in the context of T
cell-B cell interactions (Noelle et at., 1992; Splawski et al., 1993; and Grabstein et al.,
1993).

As mentioned previously, B cell stimulation has been achieved using anti-

CD40 monoclonal antibodies, or a CD40 Hgand-Fc fusion protein, in the presence of
costimulus (i.e., cytokines, anti-CD20 or anti-Ig) (Splawski et al., 1993; and Grabstein
et al., 1993). B cell proliferation can be promoted by crosslinking of CD40 using the
G28-5 monoclonal antibody (Clark and Ledbetter, 1986) or by crosslinking with antiCD40 covalently attached to latex beads (Luxembourg and Cooper 1994). Crosslinking
appears to be a requirement for CD40 signaling of monocyte IL-1 synthesis, as well,
IgGl anti-CD40 (G28-5) was ineffective, whereas an IgM anti-CD40 (BL-C4), was
proficient in the induction o f IL-1. Crosslinking of G28-5 with the addition o f an
F(ab’)2 allowed for the IL-1 signaling event to occur (Figure 5). The success of the
BL-C4 IgM anti-CD40 in signaling may be due to the crosslinking ability of pentameric
IgM or due to differences in the epitope to which BL-C4 binds. It has recently been
suggested that two CD40 epitopes may exist in murine systems (Heath et al., 1994). It
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was shown that two different monoclonal antibodies generated against murine B cell
CD40 differed in their ability to activate the B cells and that the two antibodies could
not cross block one another. Human monocytes and B cells, may also have two CD40
epitopes. It is possible that the differences between G28-5 and BC-L4 in their ability to
activate monocyte IL-1 synthesis may be due to their epitope specificity. -The
specificity of the BL-C4 generated signal was assured by the ability of the
nonstimulatory G28-S to block activation initiated by BL-C4. The ability of G28-5 to
block BL-C4 activity does not preclude the existence o f two CD40 epitopes. If the
epitopes are in close association, G28-5 may result in stearic hinderance, partially
blocking BL-C4's ability to bind to its epitope.
In a previous report, CD40 ligand-transfected cells were found to induce
monocyte IL-6 and TNFa production, but only in the presence of costimulatory
cytokines (GM-CSF, IL-3, or IFNy) (Alderson et al., 1993). When membranes
prepared from CD40L (T-BAM) transfectants, or from the Jurkat variant, D l . l , which
express high levels of CD40L (T-BAM) (Lederman et al., 1992) were used in
monocyte metabolic labeling experiments, they were not effective by themselves in
inducing IL-1 (data not shown). Since TmA, alone, induced substantial amounts of IL1, it is likely that T cell specific determinants in addition to CD40L are required for
activation, and that these additional signals are mimicked by crosslinking CD40
molecules on monocyte cell surfaces as demonstrated by crosslinking of the IgG antiCD40 and suggested by the activity of BL-C4. Other studies using adherent antibodies
have implicated costimulatory molecules such as LFA-3:CD2. In the current study,
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blockade of CD2:LFA-3, ICAM-1 :LFA-1, and CD80;CD28 interactions did not affect
activated T cells' ability to induce IL-1 synthesis in adherent monocytes. Although
studies using antibody activation of monocyte receptors are enlightening, specific
antibody blockade of signals generated by fixed T cells and T cell plasma membranes
may best reveal the extent to which potential receptor-Iigand pairs are contributing to
functional intercellular signaling.
Preliminary experiments presented here (Figure 10), as well as a report from
another laboratory (Dayeret al., 1993), suggest that the additional costimulatory
molecule on activated T cells required for induction of monocyte IL-1 synthesis may be
CD69. Experiments herein demonstrated that plasma membranes from D l.l
(CD40L+, CD 69) incubated with plasma membranes from HUT-78 (CD40L10, CD69+)
induced IL-1 synthesis. The effects of the combined membranes were synergistic. The
ligand for CD69 has not been identified so its presence on monocyte cell surfaces has
yet to be determined.
Ultimately, the cell surface contact-mediated interactions result in activation of
signaling pathways which induce IL-1 synthesis. It has been suggested that the CD40
signaling pathway in B cells employs a PTK pathway including member kinases such as
p56,yn (Ren et al., 1994). Results in the current study suggested that anti-CD40
signaling in monocytes also utilizes a PTK mediated pathway. Experiments
demonstrated that herbimycin A, a potent PTK inhibitor, blocked BL-C4's ability to
induce IL -lp in monocytes. H-7 and staurosporine, inhibitors of PKC pathways, did
not block anti-CD40 mediated IL-1 induction suggesting that PKC mediated pathways
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are not employed by anti-CD40 signaling. All inhibitors were used at concentrations
that did not abrogate total protein synthesis as shown in Figure 11. These findings are
similar to those reported in B cell studies which suggest that PTK but not PKC
pathways are activated in T cell:B cell CD40 interactions (Marshall et al., 1994).
CD40 has been described as a member o f the TNFa receptor superfamily
(Banchereau et al., 1994a). Members of this superfamily are so designated by
homologies within the extracellular domains. However, the cytoplasmic domains are
quite varied. This suggests that a variety of signaling pathways may be employed by
the various receptors. One such signaling pathway which has been implicated in signal
transduction through the TN Fa receptor is the sphingomyelin pathway (Kolesnick and
Golde, 1994; and Yang et al., 1993). Sphingomyelin is cleaved by sphingomyelinase
to generate ceramide and phosphocholine. Ceramide in turn activates a PTK cascade
which results in activation o f Raf leading to activation of NF- kB, a cytoplasmic nuclear
transcription factor (Yang et al., 1993).

While it has not been demonstrated directly,

this pathway would be consistent with the results reported here showing that anti-CD40
signaling in monocytes leads to NF-kB activation (Figure 12) and that anti-CD40
signaling activates a PTK regulated pathway (Figure 13). It has been demonstrated that
antibody blockade of the CD40:CD40L interaction between T cells and B cells prevents
activation of NF- kB (Calmanach-Girard et al., 1994). As stated earlier, an NF- kB
enhancer element is located in the human IL -lp gene, however the contribution of NFkB binding within the IL-lp gene has not been determined.

It has been reported for LPS induction o f monocyte IL-1 transcription/translation

that at least two transcription factors are required, NF-pA (Shirakawa et al., 1993;)
and NF-IL6 (Buras et al., 1994). It is not known yet if both/either of these
transcription factors are required for TmA induction of IL-1. Furthermore, the entire
complement of transcription factors necessary and sufficient for IL-1 induction is not
known. Since CD40L:CD40 interaction alone is not sufficient for IL-1 induction, as
demonstrated by the failure o f D l.l (CD40L+) plasma membranes to induce IL-1, it is
likely that the combination of signals provided by both CD40 signaling and the other
required cell contact-mediated signal (potentially provided by CD69) results in
activation of the IL-1 transcription factors.
Two regulatory sequences have been identified in the IL -lp gene which are
reported to be required for IL-1 induction, and mutations or deletions within either of
these regions prevented IL-1 transcription (Shirakawa et al., 1993; and Buras et al.,
1994). The cap site-proximal region, lies just upstream of the start codon and includes
the TATA box as well as several transcription factor elements including binding sites
for NF- kB, NF-IL6 and NF-pA. The LPS/PMA responsive region, is much further
upstream and includes many of the same transcription factor elements (Figure 14).
Future work includes determining the transcription factors required for IL-1 induction
that are activated through anti-CD40 signaling. In addition, it will be necessary to
determine which transcription factors are activated through the secondary cell contactmediated costimulus (likely CD69L) signaling, Additional aspects of this study
determined the effects of either TmAor anti-CD40 on the expression of
monocyte/macrophage cell surface molecules such as LFA-3, ICAM-1, CD80 (BB-1)
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Figure 14. Responsive regions in the IL -lp gene.
Responsive regions have been identified in the IL-lp gene which have been
demonstrated to be essential for IL-1 induction (Fenton et at., 1987; and Shirakawa et
al., 1993). These regions include the cap site-proximal region which is just upstream
of the start codon, and the LPS/PMA responsive region which is further upstream.
Several enhancer binding elements, including NF- kB, NF-IL-6, and NF-pA, have been
mapped in these regions. This cartoon is a representation of the map of the IL-1 p gene
enhancer regions.
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and C 040. ICAM-1 is thought to participate primarily as an adhesion molecule with
little if any costimulatory activity (Springer, 1990). The effects of anti-CD40 and TmA
to increase cell surface expression of ICAM-1 may be relevant to maintenance of cell
cell interactions. Upregulation of ICAM-1 would provide a cellular "glue" to allow
receptor - ligand pairs that lead to signaling events to maintain contact for longer
periods o f time. For instance, CD40L is transiently expressed on activated T cells
(Lederman et al., 1992) and ICAM-1 binding to its ligand, LFA-1, could facilitate
interactions of CD40L with CD40 on monocytes by maintaining conjugate formation
between the two cell types. TmAuregulation of LFA-3 and CD40 expression on
monocytes may be indicative of interactions which facilitate expression of signal
transducing molecules. Increased cell surface expression of these signaling molecules
would lead to an increased likelihood of receptor - ligand encounters and therefore
increased likelihood of a successful signaling event. The interpretatoin of TmA
upregulation o f CD80 is unclear since a functional role of CD80 in monocyte (APC)
signaling has not been determined. Interestingly, LFA-3 expression was not affected
by anti-CD40, suggesting that cell surface molecules other than CD40L on activated T
cells are required to upregulate LFA-3 expression. It was determined in this study
however that LFA-3 - CD2 interactions had little effect on activated T cells ability to
induce IL-1 synthesis in monocytes.
In summary we have demonstrated that CD40L on activated T cells interacting
with CD40 on adherent monocytes is critical for the induction of IL-1 synthesis in
monocytes. The finding by Durie et al.(1993) that point mutations in the CD40L result
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in X-l inked hyper IgM syndrome, a disease that diminishes humoral immunity since B
cells cannot switch from the IgM antibody class, emphasizes the crucial contribution of
CD40-CD40L signaling in T cell activation of B cell function.

Since patients with this

deficiency do not appear to have overt defects in cellular immunity, it has been
suggested that a functional CD40L is essential only to antibody-mediated immunity.
However, the ability of 5c8 to block the T cell contact-dependent signal suggests that
the CD40-CD40L interactions may make a significant contribution to the induction of
inflammatory cytokines. The kinetics of expression of CD40L with activation suggests
that after an antigen-specific activation event, CD4+ T cells have a time-limited
capacity to activate IL-1 production in resting monocytes through cell contact, hence
perpetuating inflammatory responses in the absence of further antigenic stimulus.
The effects o f blocking the CD40L:CD40 interaction after the induction of
arthritis in mice has been demonstrated. Durie e ta /., (1993) showed if mice are
treated with an anti-CD40L antibody during the induction of arthritis, the arthritic
symptoms arc ablated. They reported that joints did not become inflamed, there was
no demonstration of infiltration of inflammatory cells into subsynovial tissue, and no
evidence of bone and cartilage destruction. These authors assert that the prevention of
these typical arthritic effects arises from prevention of antibody production via T cell:B
cell interactions. However, all of these deleterious effects in the arthritis model are
also mediated through IL-1 (Banchereau et al., 1994a). The current study has
demonstrated that through CD40L:CD40 interactions between T cells and
macrophages, IL-1 is induced in monocytes. The prevention of the tissue damage seen
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in anti-CD40L treated arthritic mice may result from blockade o f activated T cell's
ability to induce IL-i in monocytes.
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